Exact Sciences
EXAS
#1381
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of June 2024 : NZ$1.53 B

According to Exact Sciences's latest financial reports the company has NZ$1.53 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.22 B23.52%
2022-12-31NZ$0.99 B-33.84%
2021-12-31NZ$1.50 B-41.19%
2020-12-31NZ$2.55 B433.22%
2019-12-31NZ$0.47 B-71.36%
2018-12-31NZ$1.67 B180.12%
2017-12-31NZ$0.59 B33.15%
2016-12-31NZ$0.44 B0.05%
2015-12-31NZ$0.44 B24.54%
2014-12-31NZ$0.36 B122.14%
2013-12-31NZ$0.16 B23.03%
2012-12-31NZ$0.13 B10.25%
2011-12-31NZ$0.11 B-3.66%
2010-12-31NZ$0.12 B268.01%
2009-12-31NZ$33.74 M294.28%
2008-12-31NZ$8.55 M-47.46%
2007-12-31NZ$16.28 M-45.55%
2006-12-31NZ$29.91 M-40.07%
2005-12-31NZ$49.91 M-29.16%
2004-12-31NZ$70.46 M64.73%
2003-12-31NZ$42.77 M-48.94%
2002-12-31NZ$83.77 M-38.8%
2001-12-31NZ$0.13 B129.17%
2000-12-31NZ$59.73 M778.5%
1999-12-31NZ$6.79 M-59.4%
1998-12-31NZ$16.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.15 B-89.72%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.38 B-75.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.72 M-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.77 B 669.36%๐Ÿ‡ซ๐Ÿ‡ท France